224.53
0.29%
-0.62
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $224.53, with a volume of 688.92K.
It is down -0.29% in the last 24 hours and down -7.89% over the past month.
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$225.15
Open:
$225.2
24h Volume:
688.92K
Relative Volume:
0.57
Market Cap:
$65.14B
Revenue:
$20.18B
Net Income/Loss:
$1.73B
P/E Ratio:
40.75
EPS:
5.51
Net Cash Flow:
$3.07B
1W Performance:
-4.31%
1M Performance:
-7.89%
6M Performance:
-4.99%
1Y Performance:
-3.76%
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
BDX | 224.51 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
ISRG | 532.68 | 190.83B | 7.87B | 2.24B | 586.00M | 4.25 |
ALC | 85.94 | 42.50B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD | 239.00 | 35.17B | 4.81B | 1.11B | 1.35B | 6.16 |
WST | 306.52 | 22.30B | 2.88B | 499.60M | 321.60M | 7.41 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
May-30-23 | Resumed | Morgan Stanley | Overweight |
May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Mar-18-22 | Resumed | Raymond James | Mkt Perform |
Mar-02-22 | Resumed | BofA Securities | Neutral |
Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
May-25-21 | Initiated | Barclays | Equal Weight |
Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
Jun-01-20 | Resumed | Goldman | Buy |
Mar-05-20 | Initiated | Citigroup | Neutral |
Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
Dec-07-18 | Initiated | Deutsche Bank | Buy |
Oct-16-18 | Initiated | Barclays | Equal Weight |
Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
Jan-19-18 | Resumed | BofA/Merrill | Buy |
Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
Jan-03-18 | Initiated | Evercore ISI | Outperform |
Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Becton, Dickinson and Company (NYSE:BDX) Position Raised by CIBC Asset Management Inc - MarketBeat
Coastline Trust Co Lowers Stock Holdings in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch
BD withdraws from talks over closure of Drogheda plant - RTÉ News
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
YieldBoost Becton, Dickinson To 11% Using Options - Nasdaq
Haverford Trust Co Sells 4,672 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Raises Holdings in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
First Eagle Investment Bolsters Stake in Becton Dickinson & Co i - GuruFocus.com
First Eagle Investment Bolsters Stake in Becton Dickinson & Co in Q3 2024 - Yahoo Finance
Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Hemenway Trust Co LLC - MarketBeat
Versor Investments LP Acquires 4,203 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Shares Purchased by Assetmark Inc. - MarketBeat
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Lorne Steinberg's Top Picks: Adobe, Becton Dickinson and Co. and Techtronic Industries - BNN Bloomberg
Are Investors Undervaluing Becton, Dickinson and Company (BDX) Right Now? - Yahoo Finance
Diamond Hill Capital Management Inc. Has $345.87 Million Holdings in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton Dickinson sees FY25 adjusted EPS $14.25-$14.60, consensus $14.34 - TipRanks
Equitable Trust Co. Acquires 3,426 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Q4 2024 Earnings Call Transcript - Insider Monkey
Becton Dickinson & Co (BDX) Q4 2024 Earnings Call Highlights: St - GuruFocus.com
Becton Dickinson Outpaces Forecasts Thanks To Device Demand - Finimize
Becton Dickinson & Co (BDX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Becton Dickinson: Fiscal Q4 Earnings Snapshot - Shelton Herald
Becton, Dickinson Reports Strong Fiscal 2024 Results - TipRanks
BD Board Increases Dividend for 53rd Consecutive Year - Quantisnow
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results - citybiz
Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth - Yahoo Finance
Becton Dickinson reports Q4 adjusted EPS $3.81, consensus $3.77 - TipRanks
Looking for a Growth Stock? 3 Reasons Why Becton Dickinson (BDX) is a Solid Choice - Yahoo Finance
Becton Dickinson & Co (BDX) Trading Down 3.69% on Nov 7 - GuruFocus.com
Becton Dickinson Profit Rises as Acquisition Buoys SalesUpdate - Marketscreener.com
Becton Dickinson Q4 earnings beat estimates, stock dips - Investing.com
Becton Dickinson Fiscal 4Q Profit Rises as Acquisition Buoys Sales - Marketscreener.com
Becton Dickinson beats quarterly estimates on strength in drug-delivery devices - Reuters
Becton Dickinson (BDX) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Becton Dickinson earnings beat by $0.04, revenue topped estimates - Investing.com UK
Becton Dickinson & Co (BDX) Q4 Earnings: EPS at $1.45, Revenue H - GuruFocus.com
BD (BDX) Reports Better than Expected Results for Q4 Fiscal 2024 - The Tokenist
Becton, Dickinson and Company Reports Earnings Results for the Fourth Quarter Ended September 30, 2024 - Marketscreener.com
BD Board Increases Dividend for 53rd Consecutive Year - Benzinga
Becton Dickinson & Co. stock rises Wednesday, still underperforms market - MarketWatch
Becton, Dickinson and Company (NYSE:BDX) Stock Position Cut by Impax Asset Management Group plc - MarketBeat
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Needle Market Is Booming Worldwide 2025-2030 | Becton Dickinson - openPR
First National Bank of Mount Dora Trust Investment Services Sells 2,911 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Insights Into Becton Dickinson (BDX) Q4: Wall Street Projections for Key Metrics - Yahoo Finance
Becton, Dickinson and Company (BDX): Expanding Innovations in Medical Technology - Insider Monkey
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):